CD8A and COVID-19: This is consistent with the findings of Yu Bai, which indicate that the number of CD4 and CD8 T cells in the peripheral blood was significantly decreased in COVID-19 patients and that the severe damage during the late stage was immune-related rather than virus-related (6).